---

Faculty
Sherrie Seller DNP, WHNP-BC
Clinical Assistant Professor, University of Missouri at Kansas City
Kansas City, MO

Target Audience New graduate women’s health nurse practitioners (WHNPs), and other nurse practitioners involved in women’s and gender related healthcare.

Approval CE Approval Period: April 4, 2022, through April 4, 2025
Post-tests must be completed during the approval period with a passing score of 70% or higher to earn CE. No refunds will be issued if the activity is not completed within the approval period.
This activity has been approved for 1.25 continuing education contact hours

Objectives

1. Pharmacokinetic, pharmacodynamic, and pharmacogenitic properties of drugs.
2. Changes in pharmacokinetics and dynamics that occur during pregnancy.
3. Legal issues related to prescribing drugs

Content Outline

1. Pharmacokinetic, pharmacodynamic, and pharmacogenitic properties of drugs.
2. Changes in pharmacokinetics and dynamics that occur during pregnancy.
3. Legal issues related to prescribing drugs.

Accreditation StatementThis activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health (NPWH) for 1.25 continuing education contact hours.

Faculty Disclosures Sherrie Sellers DNP, WHNP-BC has no disclosures.

Successful Completion Requires participants to:

1. Read the objectives, disclosures, and disclaimers.
2. Watch the activity and review the handout.
3. Complete the post-test with a score of 70% or higher.
4. Complete the session evaluation.
5. Print your CE certificate.
6. Go to your profile to view all earned certificates.

Commercial Support This activity has no commercial support.